<DOC>
	<DOCNO>NCT00769015</DOCNO>
	<brief_summary>This randomize , control clinical trial , Low Vision Depression Prevention TriAL ( VITAL ) , test efficacy collaborative low vision rehabilitation ( LVR ) prevent depressive disorder Age-Related Macular Degeneration ( AMD ) . In innovative intervention , low vision occupational therapist collaborates low vision optometrist develop implement care plan base subject 's vision status , rehabilitation potential , personal rehabilitation goal . An independent rater mask treatment assignment ass depressive disorder meet DSM-IV criterion ( primary outcome ) target vision function vision-related quality life ( secondary outcome ) baseline 4 month evaluate short-term effect ( main trial end point ) 12 month evaluate long-term effect .</brief_summary>
	<brief_title>Low Vision Depression Prevention Trial Age Related Macular Degeneration</brief_title>
	<detailed_description>Age-related macular degeneration ( AMD ) lead cause blindness old person U.S. affect 10 million people . One third patient AMD become clinically depressed lose ability pursue value activity . Because depression disable unlikely treat , prevent depression AMD public health imperative population age . We recruit 200 subject bilateral AMD subthreshold depressive symptom . Their bilateral vision loss subthreshold depressive symptom increase risk develop severe depressive disorder functional decline . We randomize eligible subject collaborative Low Vision Rehabilitation ( LVR ) ( optometrist home-based OT ) enhance LVR ( optometrist home-based Supportive Therapy ) . In study , usual care LVR enhance Supportive Therapy ( ST ) , standardized placebo psychological treatment control attention . Many old person AMD understandably become depressed vision loss prevents pursue value goal . This necessitate disease management strategy combine treatment vision loss depression . Because depression AMD rarely treat , prevent depression sensible wait treat diagnosis fail treat . As population age people affect AMD , find way prevent depression improve daily function great public health importance . For reason , VITAL Trial high clinical significance patient AMD , wider public health significance society confronts challenge care grow population old adult chronic disability .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Macular Degeneration</mesh_term>
	<mesh_term>Vision , Low</mesh_term>
	<criteria>Age least 65 year old Bilateral AMD Subthreshold depressive symptom At least 1 vision goal important yet difficult carry Uncontrolled glaucoma , diabetic retinopathy , corneal dystrophy , cataracts surgery within 6 month likely exclusionary condition Current diagnosis depression Cognitive impairment Lifethreatening illness health condition interfere study activity . Patients receive low vision rehabilitation homebased OT precede 12 month exclude .</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>age-related macular degeneration</keyword>
	<keyword>depression</keyword>
	<keyword>vision loss</keyword>
</DOC>